The F.D.A. is expected to approve a new round of shots by Pfizer and Moderna as early as Monday to prepare Americans for the fall and winter season when infections usually tick upward.
Tag: BioNTech SE
-
Pancreatic Cancer Vaccine Shows Promise in Small Trial
Using mRNA tailored to each patient’s tumor, the vaccine may have staved off the return of one of the deadliest forms of cancer in half of those who received it.
-
China’s New Premier Needs to Revive Growth. How Far Will Loyalty Get Him?
Li Qiang’s business-friendly reputation could bolster confidence in China’s economy. But he is stepping into a role with diminished power under Xi Jinping.
-
China’s Abrupt Covid Pivot Leaves Many Without Medicines
Millions are desperate to get their hands on fever-reducing drugs and antivirals such as Pfizer’s Paxlovid as infections across China outpace supplies.
-
Study Shows New Covid Booster Improves Protection for Older People, Pfizer Says
Federal officials are hoping that the encouraging results will spur more Americans to get an updated booster before a feared surge in coronavirus cases this winter.